A 75-year-old male patient returned to our centre for peritoneal dialysis after transplantectomy due to renal transplant rejection. Routine viral screening prior to resuming dialysis indicated anti-Hepatitis B (anti-HB titre of 363 IU/L \[anti-Hepatitis Bcore (anti-HBc) and Hepatitis Be antigen (HBeAg) both negative\], which suggested that the patient received hepatitis B vaccination. However, both patient and the referring centre denied vaccination. The patient's anti-HB titres decreased over time ([Table 1](#sfz035-T1){ref-type="table"}).

###### 

Course of anti-HB titres and relevant events

  Date               Event               Anti-HB titres (IU/L)
  ------------------ ------------------ -----------------------
  June 2017          Dialysis                   \<3, 10
  October 2018       IVIG therapy       
  October 2018       Transplantectomy   
  5 November 2018    Blood test                   363
  29 November 2018   Blood test                   195
  13 December 2018   Blood test                   101

During anti-rejection therapy, the patient received intravenous immunoglobulin (IVIG) therapy. The possibility of passive transfer of hepatitis B antibodies after IVIG administration resulting in false-positive hepatitis B serology and partial passive immunization following IVIG has been described \[[@sfz035-B1]\].

Attention to the possibility of this passive immunization is important, as it can lead to misinterpretation of test results with implications for further treatment. This phenomenon may be more prevalent with the increased use of IVIG in transplant rejection nowadays.
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